Delivery Order SPE2DB20D2104-SPE2DB25FMSKE

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,553.76 firm fixed-price delivery order is for the supply of 4568327612 - MULTAQ 400 MG TABLET 60S. The contract has a completion date of May 22, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $17,589.32 firm-fixed-price delivery order contract is for the provision of "MULTAQ 400 MG TABLET 60S", a prescription medication. The contract has an ultimate completion date of November 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $4,657.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4565892009 - MULTAQ 400 MG TABLET 60S, a prescription pharmaceutical product, with an ultimate completion date of September 23, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,576.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of February 21, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $16,603.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of November 20, 2024. The contract is a delivery order awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $62,531.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a period of performance through July 11, 2024. The contract is a firm fixed price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,940.02 delivery order contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 12, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,589.64 firm fixed-price delivery order contract is for the supply of 4568161327 - MULTAQ 400 MG TABLET 60S, with a performance period through May 7, 2025. AmerisourceBergen Drug Corp is the prime contractor for this non-set-aside contract. The company holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,076.34 firm fixed-price delivery order contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of January 3, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,099.60 firm fixed-price delivery order contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a period of performance through March 12, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMSKE
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,371.76 firm fixed price delivery order is for the supply of 4568440321 - MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of June 4, 2025. Amerisourcebergen Drug Corp is also the holder of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides comprehensive global pharmaceutical support to military healthcare programs through December 2026. The contract does not have a set-aside designation, indicating open competition.

Generated 9/2/25, 9:51 AM